APA
Jandrey E. H. F., Moura R. P., Andrade L. N. S., Machado C. L., Campesato L. F., Leite K. R. M., Inoue L. T., Asprino P. F., da Silva A. P. M., de Barros A. C. S. D., Carvalho A., de Lima V. C., Carraro D. M., Brentani H. P., da Cunha I. W., Soares F. A., Parmigiani R. B., Chammas R., Camargo A. A. & Costa É. T. (2019). NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. : NPJ breast cancer.
Chicago
Jandrey Elisa H F, Moura Ricardo P, Andrade Luciana N S, Machado Camila L, Campesato Luiz Felipe, Leite Katia Ramos M, Inoue Lilian T, Asprino Paula F, da Silva Ana Paula M, de Barros Alfredo Carlos S D, Carvalho Andre, de Lima Vladmir C, Carraro Dirce M, Brentani Helena P, da Cunha Isabela W, Soares Fernando A, Parmigiani Raphael B, Chammas Roger, Camargo Anamaria A and Costa Érico T. 2019. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. : NPJ breast cancer.
Harvard
Jandrey E. H. F., Moura R. P., Andrade L. N. S., Machado C. L., Campesato L. F., Leite K. R. M., Inoue L. T., Asprino P. F., da Silva A. P. M., de Barros A. C. S. D., Carvalho A., de Lima V. C., Carraro D. M., Brentani H. P., da Cunha I. W., Soares F. A., Parmigiani R. B., Chammas R., Camargo A. A. and Costa É. T. (2019). NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. : NPJ breast cancer.
MLA
Jandrey Elisa H F, Moura Ricardo P, Andrade Luciana N S, Machado Camila L, Campesato Luiz Felipe, Leite Katia Ramos M, Inoue Lilian T, Asprino Paula F, da Silva Ana Paula M, de Barros Alfredo Carlos S D, Carvalho Andre, de Lima Vladmir C, Carraro Dirce M, Brentani Helena P, da Cunha Isabela W, Soares Fernando A, Parmigiani Raphael B, Chammas Roger, Camargo Anamaria A and Costa Érico T. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. : NPJ breast cancer. 2019.